Thiolactomycin is a novel reversible dual inhibitor of D-Aspartate oxidase (DDO) and D-amino acid oxidase (DAO). References: Durairaj DR, Shanmughavel P. In Silico Drug Design of Thiolactomycin Derivatives Against Mtb-KasA Enzyme to Inhibit Multidrug Resistance of Mycobacterium tuberculosis. Interdiscip Sci. 2017 Aug 30. doi: 10.1007/s12539-017-0257-0. [Epub ahead of print] PubMed PMID: 28856604.

纯度：≥98%

CAS：82079-32-1